188
Garlid KD, Dos Santos P, Xie ZJ, Costa AD, Paucek P (2003) Mitochondrial potassium transport:
the role of the mitochondrial ATP-sensitive K+ channel in cardiac function and cardioprotec-
tion. Biochim Biophys Acta 1606:1–21
Gateau-Roesch O, Argaud L, Ovize M (2006) Mitochondrial permeability transition pore and post-
conditioning. Cardiovasc Res 70:264–273
Goetze JP, Hilsted LM, Rehfeld JF, Alehagen U (2014) Plasma chromogranin A is a marker of
death in elderly patients presenting with symptoms of heart failure. Endocr Connect 3:47–56
Gomez L, Thibault HB, Gharib A, Dumont JM, Vuagniaux G, Scalfaro P et al (2007) Inhibition of
mitochondrial permeability transition improves functional recovery and reduces mortality fol-
lowing acute myocardial infarction in mice. Am J Physiol Heart Circ Physiol 293:H1654–H1661
Goodman MD, Koch SE, Fuller-Bicer GA, Butler KL (2008) Regulating RISK: a role for JAK-
STAT signaling in postconditioning? Am J Physiol Heart Circ Physiol 295:H1649–H1656
Gottlieb RA, Finley KD, Mentzer RM Jr (2009) Cardioprotection requires taking out the trash.
Basic Res Cardiol 104:169–180
Gross ER, Hsu AK, Gross GJ (2006) The JAK/STAT pathway is essential for opioid induced car-
dioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3beta. Am J Physiol Heart Circ
Physiol 291:H827–H834
Halestrap AP (2006) Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem
Soc Trans 34:232–237
Halestrap AP (2009) Mitochondria and reperfusion injury of the heart--a holey death but not
beyond salvation. J Bioenerg Biomembr 41:113–121
Hausenloy DJ, Yellon DM (2007a) Preconditioning and postconditioning: united at reperfusion.
Pharmacol Ther 116:173–191
Hausenloy DJ, Yellon DM (2007b) Reperfusion injury salvage kinase signalling: taking a RISK for
cardioprotection. Heart Fail Rev 12:217–234
Hausenloy DJ, Yellon DM (2008) Preconditioning and postconditioning: new strategies for cardio-
protection. Diabetes Obes Metab 10:451–459
Hausenloy DJ, Lecour S, Yellon DM (2011) Reperfusion injury salvage kinase and survivor acti-
vating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two
sides of the same coin. Antioxid Redox Signal 14:893–907
Helle KB (2004) The granin family of uniquely acidic proteins of the diffuse neuroendocrine sys-
tem: comparative and functional aspects. Biol Rev Camb Philos Soc 79:769–794
Helle KB, Metz-Boutigue MH, Aunis D (2001) Chromogranin A as a calcium binding precursor
for multiple regulatory peptides for the immune, endocrine and metabolic systems. Curr Med
Chem 1:119–140
Helle KB, Corti A, Metz-Boutigue MH, Tota B (2007) The endocrine role for chromogranin A: a
prohormone for peptides with regulatory properties. Cell Mol Life Sci 64:2863–2886
Hoffman JW Jr, Gilbert TB, Poston RS, Silldorff EP (2004) Myocardial reperfusion injury: etiol-
ogy, mechanisms, and therapies. J Extra Corpor Technol 36:391–411
Hou J, Xue X, Li J (2016) Vasostatin-2 inhibits cell proliferation and adhesion in vascular smooth
muscle cells, which are associated with the progression of atherosclerosis. Biochem Biophys
Res Commun 469:948–953
Iliodromitis EK, Downey JM, Heusch G, Kremastinos DT (2009) What is the optimal postcondi-
tioning algorithm? J Cardiovasc Pharmacol Ther 14:269–273
Inserte J, Garcia-Dorado D (2015) The cGMP/PKG pathway as a common mediator of cardiopro-
tection: translatability and mechanism. Br J Pharmacol 172:1996–2009
Jordan JE, Zhao ZQ, Vinten-Johansen J (1999) The role of neutrophils in myocardial ischemia-
reperfusion injury. Cardiovasc Res 43:860–878
Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW et al (2004) Glycogen synthase
kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial perme-
ability transition pore. J Clin Invest 113:1535–1549
Juhaszova M, Zorov DB, Yaniv Y, Nuss HB, Wang S, Sollott SJ (2009) Role of glycogen synthase
kinase-3beta in cardioprotection. Circ Res 104:1240–1252
C. Penna and P. Pagliaro